{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:20Z","timestamp":1772165720383,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Fund of Guangdong Province","award":["2014A020212483"],"award-info":[{"award-number":["2014A020212483"]}]},{"name":"Guangdong Province Xin-jiang supporting project","award":["KTP20190272"],"award-info":[{"award-number":["KTP20190272"]}]},{"name":"National Key Research and Development Program of China","award":["2017YFA0106300"],"award-info":[{"award-number":["2017YFA0106300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We encourage Hepatitis B virus-infected mothers to breastfeed postpartum, even when continuing pregnancy category B nucleos(t)ide analogs (NAs) treatment. However, a large proportion of the Hepatitis B virus-infected mothers were noncompliant with this breastfeeding recommendation. This study aimed to investigate the factors associated with noncompliance with breastfeeding recommendation in Hepatitis B virus-infected mothers who had received NAs treatment during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 155 mothers with chronic hepatitis B receiving NAs treatment for preventing mother-to-child transmission during the late gestation period were included and divided into exclusive breastfeeding (n\u2009=\u200963), mixed feeding (n\u2009=\u200934), and artificial feeding (n\u2009=\u200958) groups according to the postpartum feeding methods. Independent variables associated with feeding methods were analyzed using logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to the breastfeeding and mixed feeding groups, the artificial feeding group had significantly more multiparity, later postpartum timing of stopping NAs treatment, and a lower proportion of having knowledge of NAs medications (all P\u2009&lt;\u20090.05). In addition, multivariable logistic regression analysis confirmed that multiparity, later postpartum timing of stopping NAs treatment, and lacking knowledge of medication were independent factors associated with noncompliance with breastfeeding recommendation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hepatitis B virus-infected mothers who stopped NAs treatment at late postpartum period or had less knowledge of medication were more likely to be noncompliant with breastfeeding recommendation. Strengthening health education for participants taking NAs may be an important method to improve compliance with breastfeeding recommendation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-04020-z","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T05:03:03Z","timestamp":1628744583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy"],"prefix":"10.1186","volume":"21","author":[{"given":"Er-Mei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Shuo","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Yu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Shuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"4020_CR1","doi-asserted-by":"crossref","unstructured":"Lavanchy D, Kane M. Global Epidemiology of Hepatitis B Virus Infection. In: Liaw YF, Zoulim F, editors. Hepatitis B Virus in Human Diseases. Swizerland: Springer International Publishing; 2016. p. 187\u2013203.","DOI":"10.1007\/978-3-319-22330-8_9"},{"key":"4020_CR2","unstructured":"WHO. Global hepatitis report, 2017. 2017. https:\/\/www.who.int\/publications\/i\/item\/global-hepatitis-report-2017. Accessed 19 Apr 2017."},{"key":"4020_CR3","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016-2021. World Health Organization. 2016. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed 17 May 2016."},{"key":"4020_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.4254\/wjh.v7.i9.1233","volume":"7","author":"JR Lamberth","year":"2015","unstructured":"Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World J Hepatol. 2015;7:1233\u20137.","journal-title":"World J Hepatol"},{"key":"4020_CR5","volume-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"No authors","year":"2015","unstructured":"No authors. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015."},{"key":"4020_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/rmv.1801","volume":"24","author":"L Ma","year":"2014","unstructured":"Ma L, Alla NR, Li X, Mynbaev OA, Shi Z. Mother-to-child transmission of HBV: Review of current clinical management and prevention strategies. Rev Med Virol. 2014;24:396\u2013406.","journal-title":"Rev Med Virol"},{"key":"4020_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60:468\u201376.","journal-title":"Hepatology"},{"key":"4020_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10096-014-2270-0","volume":"34","author":"V Jackson","year":"2015","unstructured":"Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U, et al. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis. 2015;34:619\u201323.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4020_CR9","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374:2324\u201334.","journal-title":"N Engl J Med"},{"key":"4020_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/hep.27837","volume":"62","author":"HL Chen","year":"2015","unstructured":"Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62:375\u201386.","journal-title":"Hepatology"},{"key":"4020_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1\u201398.","journal-title":"Hepatol Int"},{"key":"4020_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"EASL. European Association for the Study of the Liver (EASL)","year":"2017","unstructured":"EASL. European Association for the Study of the Liver (EASL). 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370\u201398.","journal-title":"J Hepatol"},{"key":"4020_CR13","doi-asserted-by":"publisher","first-page":"f3893","DOI":"10.1136\/bmj.f3893","volume":"346","author":"G Sarri","year":"2013","unstructured":"Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ. 2013;346:f3893.","journal-title":"BMJ"},{"key":"4020_CR14","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Chang KM, Hwang JP, Mm J, Brown RS. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance Purpose and Scope of the Guidance HHS Public Access. Hepatology. 2018;67:1560\u201399.","journal-title":"Hepatology"},{"key":"4020_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4254\/wjh.v8.i9.452","volume":"8","author":"T Piratvisuth","year":"2016","unstructured":"Piratvisuth T, Han GR, Pol S, Dong Y, Trylesinski A. Comprehensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol. 2016;8:452\u201360.","journal-title":"World J Hepatol"},{"key":"4020_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","volume":"387","author":"CG Victora","year":"2016","unstructured":"Victora CG, Bahl R, Barros AJD, Fran\u00e7a GVA, Horton S, Krasevec J, et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475\u201390.","journal-title":"Lancet"},{"key":"4020_CR17","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. second. 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/9789241549684_eng.pdf. Accessed 30 Apr 2020."},{"key":"4020_CR18","unstructured":"Association HB of CM, Association IDB of CM. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2015 Update). Infect Dis Inf. 2015;28:321\u201340."},{"key":"4020_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jvh.12839","volume":"25","author":"Y Chen","year":"2018","unstructured":"Chen Y, Xie C, Zhang Y, Li Y, Ehrhardt S, Thio CL, et al. Knowledge regarding hepatitis B mother-to-child transmission among healthcare workers in South China. J Viral Hepat. 2018;25:561\u201370.","journal-title":"J Viral Hepat"},{"key":"4020_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/AAC.01117-08","volume":"53","author":"M Mirochnick","year":"2009","unstructured":"Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, et al. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother. 2009;53:1170\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"4020_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciu798","volume":"60","author":"S Ehrhardt","year":"2015","unstructured":"Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: A review of the evidence. Clin Infect Dis. 2015;60:275\u20138.","journal-title":"Clin Infect Dis"},{"key":"4020_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijid.2019.07.023","volume":"87","author":"X Hu","year":"2019","unstructured":"Hu X, Wang L, Xu F. Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage. Int J Infect Dis. 2019;87:8\u201312.","journal-title":"Int J Infect Dis"},{"key":"4020_CR23","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1002\/jmv.26011","volume":"92","author":"LX Xiao","year":"2020","unstructured":"Xiao LX, Chen YR, Huang P, Mei YY, Pan CQ, Lin CS. The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy. J Med Virol. 2020;92:3381\u20139.","journal-title":"J Med Virol"},{"key":"4020_CR24","doi-asserted-by":"publisher","first-page":"e0121632","DOI":"10.1371\/journal.pone.0121632","volume":"10","author":"TT Tran","year":"2015","unstructured":"Tran TT, Gordon SC, Fung S, Dinh P, Yee L, Martins EB, et al. Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials. PLoS One. 2015;10:e0121632.","journal-title":"PLoS One"},{"key":"4020_CR25","doi-asserted-by":"publisher","first-page":"e2015042","DOI":"10.4084\/mjhid.2015.042","volume":"7","author":"A Montoya-Ferrer","year":"2015","unstructured":"Montoya-Ferrer A, Zorrilla AM, Viljoen J, Mol\u00e8s JP, Newell ML, Van de Perre P, et al. High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding. Mediterr J Hematol Infect Dis. 2015;7:e2015042.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4020_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/1471-2458-11-502","volume":"11","author":"Z YingJie","year":"2011","unstructured":"YingJie Z, YiHan L, Qi Y, YuGang X, YueQin Z, QingQing Y, et al. Should chronic hepatitis B mothers breastfeed? A meta analysis. BMC Public Health. 2011;11:502.","journal-title":"BMC Public Health"},{"key":"4020_CR27","first-page":"151","volume":"48","author":"O Association","year":"2013","unstructured":"Association O. GB of CM. [Clinical guidelines for the prevention of mother-to-child transmission of Hepatitis B virus]. Chinese J Obstet Gynecol. 2013;48:151\u20134.","journal-title":"Chinese J Obstet Gynecol"},{"key":"4020_CR28","first-page":"53","volume":"12","author":"S Chen","year":"2015","unstructured":"Chen S, Zhao Y, Liao X, Fu Y. [Effect of different feeding methods on mother-to-child transmission of HBV]. Nurs Pract Res. 2015;12:53\u20134.","journal-title":"Nurs Pract Res"},{"key":"4020_CR29","doi-asserted-by":"crossref","unstructured":"(SMFM) S for M-FM. Dionne-Odom J, Tita ATN, Silverman NS. #38. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214:6\u201314.","DOI":"10.1016\/j.ajog.2015.09.100"},{"key":"4020_CR30","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu GM. European Association for the Study of the Liver U. Corpechot C, Invernizzi P, Jones D, Marzioni M, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u201372.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"4020_CR31","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1128\/AAC.00514-10","volume":"55","author":"S Benaboud","year":"2011","unstructured":"Benaboud S, Pruvost A, Coffie PA, Ekou\u00e9vi DK, Urien S, Arriv\u00e9 E, et al. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, C\u00f4te d\u2019Ivoire, in the ANRS 12109 TEmAA Study, step 2. Antimicrob Agents Chemother. 2011;55:1315\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"4020_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/QAI.0b013e3182a921eb","volume":"65","author":"M Mirochnick","year":"2014","unstructured":"Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, et al. Pharmacokinetics and safety of tenofovir in hiv-infected women during labor and their infants during the first week of life. J Acquir Immune Defic Syndr. 2014;65:33\u201341.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4020_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1708131","volume":"378","author":"G Jourdain","year":"2018","unstructured":"Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. N Engl J Med. 2018;378:911\u201323.","journal-title":"N Engl J Med"},{"key":"4020_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/jvh.12785","volume":"24","author":"J Shang","year":"2017","unstructured":"Shang J, Wen Q, Wang CC, Liu K, Bai L, Tang H. Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up. J Viral Hepat. 2017;24:43\u20138.","journal-title":"J Viral Hepat"},{"key":"4020_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.18356\/7fc55a7d-en","volume":"5","author":"S Thapa","year":"1990","unstructured":"Thapa S, Williamson N. Breast-feeding in Asia: An Overview. Asia-Pacific Popul J. 1990;5:7\u201324.","journal-title":"Asia-Pacific Popul J"},{"key":"4020_CR36","unstructured":"Association IDSB of CM. [Chinese Guideline for Prevention and Treatment of Hepatitis B Virus Mother-to-Child Transmission (2019 Edition)]. Chinese J Infect Dis. 2019;37:388\u201396."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T01:07:22Z","timestamp":1673053642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04020-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-143445\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of the Third Affiliated Hospital of Sun Yat-sen University. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"551"}}